Articles

What’s on your mind?

The Windy City will host the 39th annual meeting of the Society for Neuroscience
Written byJeffrey Bouley
| 4 min read

CHICAGO—The Society for Neuroscience (SfN) is touting thelocation of its 39th annual meeting as "a hub of great science and nightlife[that] is easily accessible from points around the globe." That is certainly agood selling point, given that SfN has more than 30,000 members in 130 chaptersworldwide—but also given that some 32,000 people from across the globe areexpected to attend the Neuroscience 2009 event, being held in Chicago'sMcCormick Place South Oct. 17-21.

As SfN event organizers put it, tying the energy of theirevent to that of the Windy City, "Neuroscience 2009 will offer the unequalledscientific content you have come to expect in a world-class city." Theorganization also points to its esteemed and eclectic speakers in the past as asign of its unique energy, which have included the spiritual leader the DalaiLama, the architect Frank Gehry and Intel co-founder Andy Grove, among others.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.